Search

Your search keyword '"Stephens, Tyler"' showing total 167 results

Search Constraints

Start Over You searched for: Author "Stephens, Tyler" Remove constraint Author: "Stephens, Tyler"
167 results on '"Stephens, Tyler"'

Search Results

2. Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerability

3. Structural basis for complement receptor engagement and virus neutralization through Epstein-Barr virus gp350

5. Modulating the immunodominance hierarchy of immunoglobulin germline-encoded structural motifs targeting the influenza hemagglutinin stem

6. Potent and broad HIV-1 neutralization in fusion peptide-primed SHIV-infected macaques

7. Self-assembling SARS-CoV-2 spike-HBsAg nanoparticles elicit potent and durable neutralizing antibody responses via genetic delivery

8. A potent and broad neutralization of SARS-CoV-2 variants of concern by DARPins

9. Soluble prefusion-closed HIV-envelope trimers with glycan-covered bases

10. HIV-1 neutralizing antibodies elicited in humans by a prefusion-stabilized envelope trimer form a reproducible class targeting fusion peptide

11. Vaccine elicitation and structural basis for antibody protection against alphaviruses

12. Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A viruses

13. Potent monoclonal antibodies neutralize Omicron sublineages and other SARS-CoV-2 variants

15. Structure-based design of stabilized recombinant influenza neuraminidase tetramers

16. Fusion peptide priming reduces immune responses to HIV-1 envelope trimer base

17. Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants

18. Vaccine-elicited and naturally elicited antibodies differ in their recognition of the HIV-1 fusion peptide.

19. Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains

21. Protective human monoclonal antibodies target conserved sites of vulnerability on the underside of influenza virus neuraminidase

24. Longitudinal Analysis Reveals Early Development of Three MPER-Directed Neutralizing Antibody Lineages from an HIV-1-Infected Individual

25. Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor Antibodies

27. Enhancing Anti-SARS-CoV-2 Neutralizing Immunity by Genetic Delivery of Enveloped Virus-like Particles Displaying SARS-CoV-2 Spikes

28. Glycan repositioning of influenza hemagglutinin stem facilitates the elicitation of protective cross-group antibody responses

29. Adaptation of a Commercial Qualitative BAX ® Real-Time PCR Assay to Quantify Campylobacter spp. in Whole Bird Carcass Rinses.

30. Genetic immunization with self-assembling SARS-CoV-2 Spike-HBsAg nanoparticles

31. Diverse Murine Vaccinations Reveal Distinct Antibody Classes to Target Fusion Peptide and Variation in Peptide Length to Improve HIV Neutralization

33. A potent and broad neutralization of SARS-CoV-2 variants of concern by DARPins

34. Epstein-Barr virus gH/gL has multiple sites of vulnerability for virus neutralization and fusion inhibition

36. Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529

37. Prefusion-Stabilized Lassa Virus Trimer Identifies Neutralizing Nanobodies and Reveals an Apex-Situated Site of Vulnerability

39. Vaccine-elicitation of cross-group neutralizing protective antibodies to influenza A viruses

40. Extremely potent monoclonal antibodies neutralize Omicron and other SARS-CoV-2 variants

41. Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529

42. Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants

43. Structure-based design of stabilized recombinant influenza neuraminidase tetramers

45. Design of Alphavirus Virus-Like Particles Presenting Circumsporozoite Junctional Epitopes That Elicit Protection against Malaria

46. Multimeric nanobodies from camelid engineered mice and llamas potently neutralize SARS-CoV-2 variants

47. Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants

48. Newcastle Disease Virus-Like Particles Displaying Prefusion-Stabilized SARS-CoV-2 Spikes Elicit Potent Neutralizing Responses

49. Cryo-EM Structures Delineate a pH-Dependent Switch that Mediates Endosomal Positioning of SARS-CoV-2 Spike Receptor-Binding Domains

50. A comprehensive influenza reporter virus panel for high-throughput deep profiling of neutralizing antibodies

Catalog

Books, media, physical & digital resources